- Home
- PSNL vs BTQ Comparison
PSNL vs BTQ Comparison
Compare PSNL & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- BTQ
- Stock Information
- Founded
- PSNL 2011
- BTQ 1983
- Country
- PSNL United States
- BTQ Canada
- Employees
- PSNL N/A
- BTQ N/A
- Industry
- PSNL Medical Specialities
- BTQ
- Sector
- PSNL Health Care
- BTQ
- Exchange
- PSNL Nasdaq
- BTQ Nasdaq
- Market Cap
- PSNL 854.8M
- BTQ 728.0M
- IPO Year
- PSNL 2019
- BTQ N/A
- Fundamental
- Price
- PSNL $7.79
- BTQ $7.56
- Analyst Decision
- PSNL Strong Buy
- BTQ
- Analyst Count
- PSNL 7
- BTQ 0
- Target Price
- PSNL $10.43
- BTQ N/A
- AVG Volume (30 Days)
- PSNL 1.5M
- BTQ 5.1M
- Earning Date
- PSNL 11-04-2025
- BTQ 11-14-2025
- Dividend Yield
- PSNL N/A
- BTQ N/A
- EPS Growth
- PSNL N/A
- BTQ N/A
- EPS
- PSNL N/A
- BTQ N/A
- Revenue
- PSNL $69,103,000.00
- BTQ $405,988.00
- Revenue This Year
- PSNL N/A
- BTQ $100.70
- Revenue Next Year
- PSNL $29.83
- BTQ $669.96
- P/E Ratio
- PSNL N/A
- BTQ N/A
- Revenue Growth
- PSNL N/A
- BTQ 35.72
- 52 Week Low
- PSNL $2.83
- BTQ $0.18
- 52 Week High
- PSNL $10.95
- BTQ $16.00
- Technical
- Relative Strength Index (RSI)
- PSNL 46.21
- BTQ N/A
- Support Level
- PSNL $6.63
- BTQ N/A
- Resistance Level
- PSNL $9.89
- BTQ N/A
- Average True Range (ATR)
- PSNL 0.80
- BTQ 0.00
- MACD
- PSNL -0.21
- BTQ 0.00
- Stochastic Oscillator
- PSNL 32.79
- BTQ 0.00
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.